University Of Notre Dame Du Lac Rocket Pharmaceuticals, Inc. Transaction History

University Of Notre Dame Du Lac

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.81 $2.57 Million - $3.39 Million	-171,015 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.45 - $19.01 $40,659 - $57,467	3,023 Added 1.8%	171,015 $3 Million
Q4 2018 Feb 13, 2019	BUY	$11.21 - $23.53 $1.88 Million - $3.95 Million	167,992 New	167,992 $2.49 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.